Free Trial

Sernova (SVA) Competitors

Sernova logo
C$0.20 +0.02 (+8.11%)
As of 04/17/2025 03:58 PM Eastern

SVA vs. BCT, APS, IPA, FRX, SCYB, COM, NVH, IGX, TH, and MDNA

Should you be buying Sernova stock or one of its competitors? The main competitors of Sernova include BriaCell Therapeutics (BCT), Aptose Biosciences (APS), ImmunoPrecise Antibodies (IPA), Fennec Pharmaceuticals (FRX), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Novoheart (NVH), IntelGenx Technologies (IGX), Theratechnologies (TH), and Medicenna Therapeutics (MDNA). These companies are all part of the "biotechnology" industry.

Sernova vs.

Sernova (TSE:SVA) and BriaCell Therapeutics (CVE:BCT) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations, media sentiment, risk and community ranking.

BriaCell Therapeutics received 29 more outperform votes than Sernova when rated by MarketBeat users. However, 91.67% of users gave Sernova an outperform vote while only 68.97% of users gave BriaCell Therapeutics an outperform vote.

CompanyUnderperformOutperform
SernovaOutperform Votes
11
91.67%
Underperform Votes
1
8.33%
BriaCell TherapeuticsOutperform Votes
40
68.97%
Underperform Votes
18
31.03%

0.1% of Sernova shares are held by institutional investors. 12.1% of Sernova shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, BriaCell Therapeutics had 2 more articles in the media than Sernova. MarketBeat recorded 2 mentions for BriaCell Therapeutics and 0 mentions for Sernova. Sernova's average media sentiment score of 0.00 beat BriaCell Therapeutics' score of -0.66 indicating that Sernova is being referred to more favorably in the media.

Company Overall Sentiment
Sernova Neutral
BriaCell Therapeutics Negative

BriaCell Therapeutics is trading at a lower price-to-earnings ratio than Sernova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SernovaN/AN/A-C$35.70M-C$0.10-1.93
BriaCell TherapeuticsN/AN/AN/A-C$0.38-28.19

Sernova presently has a consensus price target of C$2.00, suggesting a potential upside of 900.00%. BriaCell Therapeutics has a consensus price target of C$15.00, suggesting a potential upside of 41.51%. Given Sernova's stronger consensus rating and higher possible upside, equities research analysts plainly believe Sernova is more favorable than BriaCell Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sernova
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33
BriaCell Therapeutics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Sernova's return on equity of 473.85% beat BriaCell Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
SernovaN/A 473.85% -119.26%
BriaCell Therapeutics N/A N/A N/A

Summary

Sernova beats BriaCell Therapeutics on 11 of the 14 factors compared between the two stocks.

Get Sernova News Delivered to You Automatically

Sign up to receive the latest news and ratings for SVA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SVA vs. The Competition

MetricSernovaBiotechnology IndustryMedical SectorTSE Exchange
Market CapC$67.30MC$119.72MC$5.30BC$5.51B
Dividend Yield7.86%3.75%5.12%6.84%
P/E Ratio-1.933.0521.8030.49
Price / SalesN/A4,155.94379.96566.94
Price / Cash6.1513.1938.2683.07
Price / Book-4.6833.726.443.52
Net Income-C$35.70M-C$90.50MC$3.21BC$300.18M
7 Day Performance17.65%2.16%2.88%3.55%
1 Month Performance8.11%-5.14%-8.63%-2.61%
1 Year Performance-55.56%86.16%11.46%11.56%

Sernova Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SVA
Sernova
N/AC$0.20
+8.1%
C$2.00
+900.0%
-57.0%C$67.30MN/A-1.931,959
BCT
BriaCell Therapeutics
N/AC$10.60
-3.8%
C$15.00
+41.5%
+0.0%C$168.68MN/A-28.195
APS
Aptose Biosciences
N/AC$3.85
-19.8%
N/A-93.7%C$165.77MN/A-0.7731Gap Up
High Trading Volume
IPA
ImmunoPrecise Antibodies
N/AC$6.50
+0.8%
N/A+0.0%C$162.08MC$19.47M-7.3080Gap Down
FRX
Fennec Pharmaceuticals
N/AC$7.58
+1.7%
N/A-48.6%C$146.18MC$34.86M-128.4010Gap Up
SCYB
Scythian Biosciences
N/AC$3.49
-5.9%
N/A+0.0%C$102.38MN/A0.00N/AHigh Trading Volume
COM
138267 (COM.TO)
N/AN/AN/AN/AC$102.19MN/A0.00N/A
NVH
Novoheart
N/AC$0.53
+1.9%
N/A+0.0%C$99.98MC$423,500.00-13.95N/A
IGX
IntelGenx Technologies
N/AC$0.58
+1.8%
N/A+0.0%C$87.32MC$1.75M-7.442,050Gap Up
TH
Theratechnologies
N/AC$2.35
+6.8%
N/A+93.3%C$74.98MC$52.22M-26.60103Analyst Revision
News Coverage
Gap Up
MDNA
Medicenna Therapeutics
N/AC$0.93
+3.3%
N/A-36.4%C$69.58MC$4,868.39-2.5620Gap Down

Related Companies and Tools


This page (TSE:SVA) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners